top of page
Search


How Can Brands Decipher Real-time Intelligence from the Vastness of Social Data? A New Paradigm for Pharma
In the highly regulated and patient-centric world of pharmaceutical launches, gaining a rapid, nuanced understanding of public perception is no longer optional—it is a critical necessity. Social listening has evolved from a simple monitoring tool into a sophisticated intelligence engine, providing real-time data that directly informs safety monitoring, brand strategy, and commercial success.

Yu-Feng Wei
7 hours ago5 min read


Vizuro and NCKU Forge Partnership to Accelerate AI-Driven Biologics Innovation
Partnership with Professor Woei-Jer Chuang of NCKU to explore AI-powered discovery in protein drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with NCKU Taipei | [October 27, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI and generative AI for drug discovery, today announced the signing of a Memorandum of Understanding (MOU) with Professor Woei-Jer Chuang, Ph.D., of the Department of Biochemistry and Molecular Biology, Na
Esther Chen
Oct 262 min read


Beyond Correlation: Apotek’s Causal Path Platform for Smarter Target Identification in Drug Discovery
Author: Chin-Lin Chen, Ph.D / Data Scientist at Vizuro Key Takeaway Drug discovery has entered the era of big data. Every year, thousands of disease and normal samples are profiled — yet one critical bottleneck remains: identifying clinically meaningful target–marker gene pairs for new drug development . The core value of Apotek Path is for this purpose: Identify disease-relevant targets → Causal modeling reveals mechanistic gene interactions tailored to your disease contex
Chin-Lin Chen
Sep 265 min read


From Correlation to Causation: Why Pharma Is Embracing Causal AI
Why causal AI is becoming pharma’s next strategic differentiator — from target validation to clinical trials and real-world evidence....
Esther Chen
Sep 76 min read


Vizuro Signs Memorandum of Understanding with Chang Gung University of Science and Technology to Advance AI-Driven Drug Discovery
Partnership with Professor Tsong-Long Hwang of CGUST to explore AI-powered innovations in small molecule drug design Vizuro Apotek AI...
Esther Chen
Aug 222 min read


Building AI-Ready Enterprises: Methods and Strategies
Author: Ting-Yuan Wang, Solution Architect at Vizuro Realities of AI Implementation Over the past eight years, Vizuro has witnessed the...

Vizuro team
Apr 107 min read


Vizuro Selected for Wet Lab Validation in Winter'24 Adaptyv Bio's EGFR Binder Design
Fig 1. Adaptyv Bio “Protein Design Competition Round2” Competition Overview Protein binding remains one of the most challenging aspects...

Vizuro team
Jan 103 min read


Vizuro and DCB Join Forces to Revolutionize Drug Discovery and Precision Medicine with Causal Generative AI
Vizuro and DCB announced the signing of a Memorandum of Understanding (MOU) Vizuro LLC, a leading innovator in multimodal causal AI...

Vizuro
Dec 25, 20243 min read


Vizuro Joins NVIDIA Inception
We are thrilled to announce that Vizuro has joined NVIDIA Inception , a program that nurtures startups revolutionizing industries with...

Vizuro
Nov 26, 20241 min read


What’s next for drug discovery after AI won the 2024 Nobel Prize in Chemistry?
Key Takeaways: The 2024 Nobel Prize in Chemistry was awarded for groundbreaking advancements in computational protein structure...

Vizuro
Oct 22, 20244 min read
bottom of page